FDA NDC Directory · JSON-LD · Markdown

AKYNZEO

NDC 69639-101 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nameNetupitant and Palonosetron
Labeler / ManufacturerHelsinn Therapeutics (U.S.), Inc.
Marketing categoryNew Drug Application (innovator) · App NDA205718
Dosage form / routeCAPSULE · ORAL
Active ingredientsNETUPITANT (300 mg/1)
PALONOSETRON (.5 mg/1)
Marketing started20141013
Package count2

External sources

Source: openFDA. Public-domain (CC0).